We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
Cap. Flow
-$348M
Cap. Flow %
-25.31%
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$53.1M
2
KSU
Kansas City Southern
KSU
+$31.9M
3
PF
Pinnacle Foods, Inc.
PF
+$27.7M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$5.3M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.43M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12.3M
2
INSM icon
Insmed
INSM
+$7.51M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$6.36M
4
DYNC
Vistra Energy Corp.
DYNC
+$5.07M
5
NXH
Neighborhood Intelligence Inc
NXH
+$3.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.94%
2 Technology 3.93%
3 Industrials 2.49%
4 Consumer Staples 2.13%
5 Healthcare 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDRM
126
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-19,000
Closed -$739K
FNSR
127
DELISTED
Finisar Corp
FNSR
– –
-83,400
Closed -$1.85M
FNSR
128
PUT
DELISTED
Finisar Corp
FNSR
– –
-21,300
Closed -$472K
DDC
129
DELISTED
Dominion Diamond Corporation
DDC
– –
-25,000
Closed -$355K
2 3 4 5
6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.

  • DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
  • DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
  • DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
  • DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
  • DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
  • DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
  • DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.